NCT05292664 2026-03-12Venetoclax Basket Trial for High Risk Hematologic MalignanciesDana-Farber Cancer InstitutePhase 1 Recruiting30 enrolled
NCT04216524 2026-03-04Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmM.D. Anderson Cancer CenterPhase 2 Recruiting40 enrolled